Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydralazine in early-stage Alzheimer's Disease
NCT04842552Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Aug 2021
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydralazine in Alzheimer's disease (AD), sponsored by Shahid Sadoughi University of Medical Sciences. Started Aug 2021; status: completed.
02
Drugs
hydralazine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT04842552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04842552.